Liu, Y <br/><br/>
Decreased warfarin clearance associated with the CYP2C9 R150H (*8) polymorphism.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Apr 2012 
 - 660-5 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-6535 
<br/><br/><label>Standard No.: </label>10.1038/clpt.2011.269  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Black or African American--genetics<br/>Aged<br/>Aryl Hydrocarbon Hydroxylases--genetics<br/>Cytochrome P-450 CYP2C9<br/>Female<br/>Genetic Variation--genetics<br/>Hep G2 Cells<br/>Humans<br/>Male<br/>Metabolic Clearance Rate--genetics<br/>Middle Aged<br/>Polymorphism, Genetic--genetics<br/>Warfarin--pharmacokinetics